The effect of topical sodium chlorite gel in treatment of cutaneous leishmaniasis
Phase 3
Recruiting
- Conditions
- Cutaneous leishmaniasis.Cutaneous leishmaniasisB55.1
- Registration Number
- IRCT20190714044200N2
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
All patients over 18 years of age with cutaneous leishmaniasis
A maximum of 4 months have passed since the onset of cutaneous leishmaniasis in patients.
Exclusion Criteria
Immunodeficient individuals
Cutaneous leishmaniasis on the face of patients
Pregnancy and lactation
Patients with more than 3 lesions of cutaneous leishmaniasis
Patients with lesions greater than 5 cm in diameter
Patients with concomitant mucosal lesions
Patients who have received systemic or topical anti-leishmaniasis medication in the last 4 weeks.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring the diameter of cutaneous leishmaniasis lesions in patients. Timepoint: At the beginning of the study, one week later, two weeks later, three weeks later, four weeks after starting treatment. Method of measurement: Measuring ruler.
- Secondary Outcome Measures
Name Time Method